SCHEMBL19251580

SCHEMBL19251580

C[C@H]1CC[C@@H](C)N(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19850985 1.00 — —
SCHEMBL10416262 1.00 — —
SCHEMBL17951396 1.00 — —
SCHEMBL24837420 0.83 ACHE (0.36) —
SCHEMBL22876921 0.81 RECQL (0.34) —
SCHEMBL2609215 0.73 — —
SCHEMBL12360 0.73 — —
SCHEMBL12570742 0.73 — —
SCHEMBL12104106 0.73 — —
SCHEMBL3430471 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10858360-B2 Tricyclic gyrase inhibitors MERCK SHARP & DOHME CORP. (US) 2020-12-08 — — US disclosed
US-10239861-B2 Therapeutic compounds and uses thereof GENETECH, INC. (US) 2019-03-26 — — US disclosed
US-20180037566-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2018-02-08 — — US disclosed
US-9732083-B2 Tricyclic gyrase inhibitors MERCK SHARP & DOHME CORP. (US) 2017-08-15 — — US disclosed
Send feedback